Bayer Group Condensed Consolidated Statements of Cash Flows

€ million

 

Q2 2025

 

Q2 2026

 

H1 2025

 

H1 2026

Income after income taxes

 

(190)

 

229

 

1,114

 

2,996

Income taxes

 

(236)

 

92

 

290

 

314

Financial result

 

439

 

506

 

933

 

1,045

Income taxes paid

 

(304)

 

(330)

 

(614)

 

(590)

Depreciation, amortization and impairment losses (loss reversals)

 

272

 

1,158

 

1,446

 

2,412

Change in pension provisions

 

(138)

 

(142)

 

(285)

 

(303)

(Gains) losses on retirements of noncurrent assets

 

(230)

 

(14)

 

(245)

 

(175)

Decrease (increase) in inventories

 

176

 

100

 

667

 

480

Decrease (increase) in trade accounts receivable

 

(127)

 

162

 

(4,588)

 

(3,415)

(Decrease) increase in trade accounts payable

 

(219)

 

(45)

 

(991)

 

(600)

Changes in other working capital, other noncash items

 

1,615

 

(1,026)

 

2,316

 

(3,268)

Net cash provided by (used in) operating activities

 

1,058

 

690

 

43

 

(1,104)

Cash outflows for additions to property, plant, equipment and intangible assets

 

(465)

 

(660)

 

(853)

 

(1,071)

Cash inflows from the sale of property, plant, equipment and other assets

 

92

 

44

 

103

 

219

Cash inflows from (outflows for) divestments less divested cash

 

 

 

(1)

 

Cash inflows from noncurrent financial assets

 

10

 

4

 

16

 

10

Cash outflows for noncurrent financial assets

 

(53)

 

(41)

 

(111)

 

(63)

Cash outflows for (inflows from) acquisitions less acquired cash

 

6

 

(295)

 

(197)

 

(300)

Interest and dividends received

 

61

 

68

 

153

 

155

Cash inflows from (outflows for) current financial assets

 

503

 

173

 

1,205

 

623

Net cash provided by (used in) investing activities

 

154

 

(707)

 

315

 

(427)

Dividend payments

 

(108)

 

(112)

 

(108)

 

(112)

Issuances of debt

 

1,554

 

1,944

 

2,495

 

3,187

Retirements of debt

 

(1,399)

 

(2,840)

 

(3,364)

 

(3,353)

Interest paid including interest-rate swaps

 

(529)

 

(469)

 

(746)

 

(671)

Net cash provided by (used in) financing activities

 

(482)

 

(1,477)

 

(1,723)

 

(949)

Change in cash and cash equivalents due to business activities

 

730

 

(1,494)

 

(1,365)

 

(2,480)

Cash and cash equivalents at beginning of period

 

4,015

 

5,728

 

6,191

 

6,671

Change in cash and cash equivalents due to exchange rate movements

 

(186)

 

48

 

(265)

 

104

Effects from hyperinflation of cash flows

 

(2)

 

7

 

(4)

 

(6)

Cash and cash equivalents at end of period

 

4,557

 

4,289

 

4,557

 

4,289